AMERICAN ANGUS ASSOCIATION - THE BUSINESS BREED

Combating BRD at Intake

To treat or not to treat when it comes to high-risk cattle.

By Lynsey McAnally, Angus Beef Bulletin Associate Editor

January 8, 2025

cattle in pin

Sometimes the best thing we can do for a pen of high-risk cattle is to treat them all, but not always. According to researchers at Purdue University, bovine respiratory disease (BRD) is responsible for half of all cattle deaths from disease in North America. The disease complex costs the beef industry $900 million annually.

With increasing public scrutiny of antibiotic use and the advent of new technologies, John Richeson — Paul Engler Professor of Beef Cattle Feedlot Management at West Texas A&M University — discusses advancements in that space on an episode of Angus at Work.

What is metaphylaxis?

By definition, metaphylaxis is the administration of antimicrobials to a group of animals to control or prevent the spread of infectious disease. In feedlots, metaphylaxis is achieved by vaccinating an incoming group of cattle with an FDA-approved antimicrobial to hopefully prevent or control BRD.

“We would typically do this in cattle that are at higher risk for a BRD outbreak,” explains Richeson. “Because it’s difficult to diagnose this disease — and because we found through research that this practice is so effective — every animal that’s classified as high-risk during initial processing might get an injection of an antimicrobial to control the disease outbreak.”

Another method to achieve the same result may be targeted metaphylaxis, he says. We know not every animal in the group receiving metaphylaxis needs an antimicrobial or will benefit from that antimicrobial treatment. Historically it’s been extremely difficult to know which animals really need treatment for BRD and who might benefit from it.

The targeted approach uses different metrics to evaluate BRD risk at the individual animal level rather than the population level. This judicious use of antimicrobials ensures they remain effective and shows consumers that their concerns for antibiotic and antimicrobial responsibility are being heard.

Regardless, feedlot staff are doing everything in their power to ensure responsibility when it comes to medications, as well as the welfare of the cattle in their care.

“We preserve [metaphylaxis] for what we call higher-risk cattle. Those cattle would be cattle that may have been procured from the auction market system and/or may have traveled a long distance to get to the feedyard or they may be lighter-weight animals,” says Richeson, noting that there are several different traditional metrics used to determine whether cattle are at higher risk for BRD. “We may classify a truckload, a pen or a lot as high-risk and make the decision whether to implement antimicrobial metaphylaxis based on relatively limited information, but we know some information about every set of cattle that we receive.”

Advancements

While individual treatment for BRD would be ideal, the reality of identifying and treating on a per animal basis has been tricky in the past. If cattle are missed, the repercussions of potential BRD spread are daunting. However, there might be some hope on the horizon for individual assessment.

“With metaphylaxis, you’re trying to predict the health risk. You’re not necessarily trying to diagnose. That makes it even more challenging because, based on a blood sample, their leukocyte count, some sort of biomarker or microbiome or genetics, we’re trying to determine whether that animal is likely to become sick three, four, five, six, seven days down the road,” acknowledges Richeson. “That makes it even more challenging to try to predict BRD outcome versus trying to diagnose it. Any kind of test ideally would be chuteside and would not require a laboratory analysis outside of the feedyard.”

There are companies offering blood-test platforms that evaluate the leukocyte count in cattle, he says. Based on research those companies have done and an algorithm they have put together, their machine is able to produce a red light or a green light indicating high or low risk for illness in the feedyard at arrival.

Other options include systems with cattle wearables that indicate via visual or data cues that an animal might need treatment.

“Whatever it is we decide to use — whether it’s [a wearable], an ear tag, a rectal temperature, or a combination of all of them — the health outcome of the population needs to be equivalent to the old method, which is to give the entire group an antimicrobial,” notes Richeson. “That’s the type of research I hope will continue over the next couple years. Hopefully, there’s more evaluation with the microbiome and understanding if microbiome signature may be correlated to health risk. On the detection side, too, just further evaluating the technologies to detect BRD would be important.”

The information above is summarized from the June 15, 2022, episode of Angus at Work. To access the full episode — including further information on BRD detection options — check out our Angus at Work archive on www.angus.org.

Angus Beef Bulletin EXTRA, Vol. 17, No. 1-A

January 2025 cover

Current Angus Beef Bulletin

Articles to help you make the most of your investment in Angus genetics.

Angus At Work Color Logo

Angus at Work

A podcast for the profit-minded commercial cattleman.